ArticleDrugs & therapy perspectives : for rational drug selection and use2018

Osimertinib as first-line therapy in advanced NSCLC: a profile of its use.

Lesley J ScottPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.